Home/Filings/4/0001127602-24-023823
4//SEC Filing

Patterson Sandra 4

Accession 0001127602-24-023823

CIK 0000882095other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 7:38 PM ET

Size

8.3 KB

Accession

0001127602-24-023823

Insider Transaction Report

Form 4
Period: 2024-09-10
Patterson Sandra
SVP, Controllership
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-10+90136,877 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-09-1090113,183 total
    Common Stock (901 underlying)
  • Tax Payment

    Common Stock

    2024-09-10$81.44/sh292$23,78036,585 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001968906

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 7:38 PM ET
Size
8.3 KB